PHILADELPHIA and LONDON, Dec. 28 /PRNewswire/ -- Thomson Reuters today announced new enhancements to its leading drug discovery database, Prous Science Integrity®, that enable scientists to quickly and easily draw together research findings from Web of Knowledge, the world's premier research platform.
"As the sheer volume of scientific information grows, research becomes more complicated, and it becomes more important than ever to provide access to trusted and comprehensive data," said Josep Prous, Jr., Ph.D., Vice President and Chief Scientific Officer at Thomson Reuters. "By connecting Prous Science Integrity to Web of Knowledge we continue to offer ways to analyze, visualize and organize information in a way that's useful for our customers."
New developments to Prous Science Integrity advance the way users search and export information within the database, and also allow users to access full text literature through a number of sources.
The enhancements will:
• Support management of research findings with new literature tools, including new export formats (EndNote, Reference Manager and RefWorks) and links to Web of Knowledge, as well as providing users with direct access to full-text scientific articles that are part of their company's internal holdings via OpenURL link resolver technologies.
• Accelerate scientific insights into the relationship of drug mechanisms, patents, and experimental pharmacology results via integrated content and visualizations.
• Enhance searching capabilities to identify relevant biomarker uses through new search fields -- for example, finding biomarkers that can predict the efficacy of drugs with a particular mechanism of action.
Prous Science Integrity, the largest commercial database available on bioactive compounds, is designed to support the drug discovery and development activities for thousands of pharmacologists and medicinal chemists as well as other scientific researchers. Find more about Prous Science Integrity here.
Web of Knowledge is today's premier research platform, helping users quickly find, analyze and share information in the sciences, social sciences, arts and humanities. Over 20 million researchers in 90 countries base their research, planning and budget decisions on the content and analytics they find in Web of Knowledge. Find out more about Web of Knowledge here.
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto Stock Exchange (TSX: TRI) and New York Stock Exchange (NYSE: TRI). For more information, go to www.thomsonreuters.com.
